Table 1.
Clinical and histopathological patient characteristics in ICON and NEOSTAR cohorts.
| Patient cohorts | ICON (chemotherapy) (n = 28) | NEOSTAR (ICIs) (n = 44) |
|---|---|---|
| Mean (SD) | Mean (SD) | |
| Age (yr) | 64.4 (8.8) | 65.6 (8.3) |
| n (%) | n (%) | |
| Sex | ||
| Female | 14 (50) | 16 (36) |
| Male | 14 (50) | 28 (64) |
| Histology | ||
| Adenocarcinoma | 19 (68) | 26 (59) |
| Squamous cell | 9 (32) | 17 (39) |
| Adenosquamous | 0 | 1 (2) |
| Clinical Stage | ||
| Stage I | 1 (3) | 23 (52) |
| Stage II | 12 (43) | 12 (27) |
| Stage III | 15 (54) | 9 (20) |
| Smoking | ||
| Never | 5 (18) | 8 (18) |
| Former | 23 (82) | 26 (59) |
| Current | 0 | 10 (23) |
n, Number of patients. ICON ImmunogenomiC prOfiling in Non-small cell lung cancer, ICIs immune checkpoint inhibitors, SD standard deviation.